|
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside |
|
CHEBI:140850 |
|
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside |
|
A stilbenoid that is trans-stilbene which has been substituted by hydroxy groups at positions 2, 3, 5, and 4', and in which the hydroxy group at positon 2 has then been converted to the corresponding the β-D-glucoside. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Ceri
|
|
|
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C20H22O9/c21-9-15-16(25)17(26)18(27)20(28-15)29-19-11(7-13(23)8-14(19)24)4-1-10-2-5-12(22)6-3-10/h1-8,15-18,20-27H,9H2/b4-1+/t15-,16-,17+,18-,20+/m1/s1 |
JAYVHSBYKLLDJC-DSNJPTTOSA-N |
O1[C@@H]([C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC2=C(C=C(O)C=C2O)/C=C/C3=CC=C(O)C=C3)CO |
|
Fallopia multiflora
(NCBI:txid7602)
|
See:
PubMed
|
antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
|
|
cyclooxygenase 2 inhibitor
A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 2.
apoptosis inhibitor
Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
cardioprotective agent
Any protective agent that is able to prevent damage to the heart.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
|
|
View more via ChEBI Ontology
Outgoing
|
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
anti-inflammatory agent
(CHEBI:67079)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
antioxidant
(CHEBI:22586)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
apoptosis inhibitor
(CHEBI:68494)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
cardioprotective agent
(CHEBI:77307)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
cyclooxygenase 2 inhibitor
(CHEBI:50629)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
has role
platelet aggregation inhibitor
(CHEBI:50427)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
is a
β-D-glucoside
(CHEBI:22798)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
is a
resorcinols
(CHEBI:33572)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
(CHEBI:140850)
is a
stilbenoid
(CHEBI:26776)
|
|
2,4-dihydroxy-6-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl β-D-glucopyranoside
|
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
|
ChEBI
|
2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
|
ChEBI
|
tetrahydroxystilbene glucoside
|
SUBMITTER
|
trans-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside
|
ChEBI
|
55327-45-2
|
CAS Registry Number
|
ChemIDplus
|
82373-94-2
|
CAS Registry Number
|
SUBMITTER
|
15015285
|
PubMed citation
|
Europe PMC
|
16201354
|
PubMed citation
|
Europe PMC
|
17613621
|
PubMed citation
|
Europe PMC
|
17701557
|
PubMed citation
|
Europe PMC
|
17963744
|
PubMed citation
|
Europe PMC
|
18422177
|
PubMed citation
|
Europe PMC
|
24332167
|
PubMed citation
|
Europe PMC
|
25382724
|
PubMed citation
|
Europe PMC
|
25557036
|
PubMed citation
|
Europe PMC
|
25571766
|
PubMed citation
|
Europe PMC
|
25916801
|
PubMed citation
|
Europe PMC
|
27275773
|
PubMed citation
|
Europe PMC
|
27341995
|
PubMed citation
|
Europe PMC
|
27565551
|
PubMed citation
|
Europe PMC
|
27698731
|
PubMed citation
|
Europe PMC
|
27776426
|
PubMed citation
|
Europe PMC
|
28112174
|
PubMed citation
|
Europe PMC
|
28410266
|
PubMed citation
|
Europe PMC
|
28920378
|
PubMed citation
|
Europe PMC
|
526837
|
Chinese Abstracts citation
|
Europe PMC
|
|